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INTRODUCTION
Different viruses are able to cause reproductive fai-
lure in gilts and sows. Viruses such as Aujeszky’s di-
sease virus (ADV), classical swine fever virus
(CSFV), porcine reproductive and respiratory syn-
drome virus (PRRSV), porcine circovirus type 2
(PCV2), porcine parvovirus (PPV) and porcine entero -
viruses (PEV) of the serotypes 1, 3, 6 and 8 (Dunne et
al., 1971) can infect embryos, fetuses and/or placentas
via transmission through semen or via the blood of vi-
remic gilts and sows (Pensaert et al., 2004; Guérin and
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ABSTRACT
A serosurvey for viruses associated with reproductive disorders was conducted in 25 conventional Belgian
farms. Serum antibody titers for porcine reproductive and respiratory syndrome virus (PRRSV), porcine
circovirus type 2 (PCV2), porcine parvovirus (PPV), porcine enteroviruses (PEV) and swine influenza viruses
(SIV) were determined in gilts and sows. All the animals were seropositive for PCV2 and >95% were
seropositive for all 4 embryopathogenic PEV serotypes. Consequently, special preventive measures appear to
be unnecessary for these viruses. In 1 farm, non-vaccinated gilts were found to run a risk of developing PPV-
induced reproductive disorders. Vaccination against PPV could exclude this risk. In 10 farms, gilts seronegative
for one or more specific SIV subtypes were introduced into a herd that had previously been infected with the
same subtypes. Vaccination of gilts against SIV may prevent reproductive disorders in gilts and respiratory
problems in their offspring. In 1 farm, newly purchased gilts that were possibly shedding PRRSV were
introduced into a PRRSV seronegative sow herd. Serological screening prior to purchase or vaccination of the
sows could have resolved this dangerous situation.
SAMENVATTING
In 25 conventionele Belgische zeugenbedrijven werden bij gelten en zeugen antistoftiters bepaald tegen virussen
die geassocieerd worden met reproductiestoornissen, meer bepaald het porcien reproductief en respiratoir syndroom
virus (PRRSV), porcien circovirus type 2 (PCV2), porcien parvovirus (PPV), porciene enterovirussen (PEV) en de
varkens influenzavirussen (SIV). Alle dieren waren sero - positief voor PCV2 en >95% was seropositief voor de 4
embryopathogene PEV-serotypen. Het lijkt bijgevolg onnodig om specifieke preventieve maatregelen te nemen tegen
deze virussen. In 1 bedrijf riskeerden niet-gevaccineerde gelten reproductie stoornissen door PPV te ontwikkelen.
Vaccinatie tegen PPV zou dit risico uitsluiten. In 10 bedrijven werden gelten die seronegatief waren voor 1 of
meerdere SIV-subtypen, geïntroduceerd in een zeugenpopulatie die voordien geïnfecteerd was met de
overeenkomstige subtypen. De vaccinatie van gelten tegen SIV zou repro ductiestoornissen bij gelten en ademhalings -
stoornissen bij hun nakomelingen vermijden. In 1 bedrijf werden aangekochte gelten die mogelijk PRRSV
verspreid den, geïntroduceerd in een PRRSV-negatieve zeugen populatie. Een serologische screening vóór de aankoop
of vaccinatie zou deze gevaarlijke situatie kunnen oplossen.
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Pozzi, 2005; Maes et al., 2008). Subsequent replica-
tion of these viruses in embryos, fetuses and/or pla-
centas will cause a return to estrus, abortion,
mummification, premature birth, late birth, stillbirth
or weak-born piglets. In Belgium, ADV and CSFV
have been eradicated, but enzootic PRRSV, PCV2,
PPV and PEV are highly prevalent in the pig popula-
tion due to virus persistence on farms. Swine influenza
viruses (SIV) do not replicate in embryos, fetuses or
placentas, but epidemic SIV infections are frequently
associated with high fever, which can also lead to re-
productive failure. The SIV subtypes H1N1, H3N2
and H1N2 are highly prevalent in Belgian pig farms
due to frequent circulation of these viruses in Belgian
pig farms (Labarque et al., 2004b). 
In Belgium, young breeding gilts are usually in-
fected after weaning with the viruses that are circula-
ting on a farm. This is the case for PRRSV, PCV2 and
PEV (De Meurichy et al., 1976; Labarque et al., 2000;
Mateusen et al., 2002; Meerts et al., 2004). The im-
mune response that eliminates this primary infection
will protect these gilts against reproductive disorders
caused by re-infection during pregnancy. However,
their immune system will not always have been pri-
med before these gilts are introduced into the sow
herd. Especially when purchased specified pathogen
free (SPF) replacement gilts are not properly vaccina-
ted or microbiologically adapted before introduction
into a conventional sow herd and before first insemi-
nation, these gilts may suffer from viral primary in-
fections during first gestation, causing severe
reproductive problems. The same problems may arise
when home-bred replacement gilts are raised in isola-
tion, putatively preventing their infection with the vi-
ruses that are circulating among the sows on the farm.
PPV and SIV may be exceptions to these general rules.
In Belgium, gilts are usually vaccinated twice against
PPV and other infectious agents such as Erisypelothrix
rhusiopathiae at the ages of 6.5 and 7.5 months, and
then inseminated at the age of 8 months. Just before
insemination, the gilts are introduced into the sow
herd. Maternally derived antibodies (Ab) generally
protect gilts against PPV infection until 5 months of
age (Paul et al., 1982). If a farmer does not vaccinate
the gilts against PPV, gilts have to be naturally infec-
ted with PPV in the 3-month period between the loss
of maternally derived Ab and insemination. If not, na-
tural PPV infection will occur during their first gesta-
tion and will cause reproductive losses in these gilts.
The 3 SIV subtypes are highly prevalent on Belgian
farms. Moreover, a previous study on Belgian farms
found the seroprevalence of these 3 subtypes to be hig-
her in sows than in gilts (Labarque et al., 2004b). Ta-
king into account that there is no good cross-protection
between the different subtypes (Van Reeth et al.,
2006), the non-vaccinated gilts may not have been ade-
quately primed before their introduction into the sow
herd.
The introduction of young gilts into a herd of preg-
nant sows may not only cause problems for the gilts,
but may also severely affect gestation in the sow po-
pulation. This is the case when the gilts introduced are
sub-clinical carriers of pathogens for which the sow
population is seronegative. This risk may be espe cially
great with PRRSV, because young gilts may be sub-
clinical PRRSV carriers for several months after in-
fection (Allende et al., 2000; Wills et al., 2003) and
viral shedding can be reactivated by transport stress
and immunosuppression (Albina et al., 1994).
Thus the introduction of gilts into sow herds, with -
out knowing the serological status of the gilts and
sows, may cause reproductive problems in the gilts or
sows due to the transmission of wild-type endemic
and/or epidemic viruses between the gilts and the
sows. In order to address this issue, serological profiles
for PRRSV, PCV2, PPV, PEV and SIV were deter -
mined in the gilts and in the sows in 25 conventional
Belgian sow herds.
MATERIALS AND METHODS
Study design
Blood was collected by field veterinarians in 25
Belgian farms representative of conventional Belgian
sow farms in terms of herd size, housing, management
and husbandry practices, sanitary status (A3 or A4),
hygienic measures (quarantine for purchased animals)
and vaccination schemes, and without a recent history
of reproductive problems. Five farms were located in
the province of West Flanders, 3 in East Flanders, 6 in
Antwerp, 6 in Flemish Brabant, 3 in Liège, 1 in Namur
and 1 in Luxembourg. Farm size ranged between 124
and 540 sows. In 20 farms, pregnant sows were kept in
individual pens; in 5 farms, they were kept in groups.
Fourteen farms used a traditional one-week manage-
ment system, 9 farms a 3-week system, 1 farm a 4-
week system and 1 farm a 5-week system. Thirteen
farms had home-bred replacement gilts, whereas 12
farms purchased replacement gilts. Blood samples
(n=10) from home-bred replacement gilts were taken
at 5-6 months of age, before vaccination against PPV.
Blood was collected from the same gilts just before in-
troduction into the sow herd. Blood samples (n=10)
from newly purchased replacement gilts were taken
when the gilts arrived in the farm. During the follo-
wing 4- to 7-week quarantine period, the gilts were
vaccinated against PPV. Just before introduction into
the sow herd, new blood samples were collected from
the same gilts. Blood samples (n=10) from sows with
at least 3 parities, representative of the sow population
of the farm, were collected on all farms.
Assay procedures
PRRSV- and PCV2-specific Ab in serum were de-
termined by an immunoperoxidase monolayer assay
(IPMA), as described previously (Wensvoort et al.,
1991; Labarque et al., 2000). Lelystad virus (Wens-
voort et al., 1991) was used as antigen for the PRRSV
IPMA, and Stoon-1010 (Meehan et al., 1998) for the
PCV2 IPMA. PPV-specific Ab and SIV H1N1-,
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H3N2- and H1N2-subtype-specific Ab were determi-
ned by hemagglutination inhibition (HI) tests, as des-
cribed previously (Palmer et al., 1975; Joo et al.,
1976). The respective antigens were Weybridge
590/63 (PPV) (Wrathall et al., 1984), Sw/ Bel-
gium/1/98 (H1N1), Sw/Flanders/1/98 (H3N2) and
Sw/Gent/7625/99 (H1N2) (Van Reeth et al., 2003a).
Seroneutralization (SN) tests (Dunne et al., 1971) were
performed to determine anti-PEV Ab specific for se-
rotypes 1, 3, 6 and 8, the serotypes that are associated
with reproductive disorders (Derbyshire, 1999). The
antigens were PS34, O2b, PS37 and PS27, respecti-
vely (Derbyshire, 1999).
Analysis of results
For every farm, the numbers of positive and nega-
tive serum samples were compared between 3 groups:
(i) gilts before vaccination, (ii) gilts at introduction into
the sow population, and (iii) multiparous sows. Anti-
body titers were expressed as the reciprocal of the last
dilution that resulted in a positive reaction in an IPMA
or that inhibited hemagglutination in an HI test or that
neutralized the virus in an SN test. The detection li-
mits of the assays, which were equal to the reciprocal
of the first dilution that was used in the assay, were 41.7
(10) for PRRSV and PCV2, 23.0 (8) for PPV, 23.3 (10)
for SIV and 21.0 (2) for PEV.
Statistical analysis
The 95% confidence intervals of the within-herd
seroprevalences were calculated as described by Da-
niel (1990).
RESULTS
Porcine reproductive and respiratory syndrome virus
For PRRSV, complete sets of serum samples were
available for 19 farms.
In 10 farms (8 with purchased replacement gilts
and 2 with home-bred replacement gilts), the gilts and
sows were vaccinated against PRRSV. In all of these
10 farms, the gilts were seropositive and they were in-
troduced into a population of seropositive sows.
In 9 farms (7 with home-bred replacement gilts and
2 with purchased replacement gilts), the gilts and sows
were not vaccinated against PRRSV. In 6 of these 9
farms (5 with home-bred replacement gilts and 1 with
purchased replacement gilts), the gilts were seroposi-
tive and they were introduced into a population of se-
ropositive sows. In 2 of the farms with home-bred
gilts, the serum samples from the gilts and the sows
were negative. In 1 farm, non-vaccinated seropositive
purchased gilts (10 positive serum samples, corres-
ponding to 73-100% within-group seroprevalence)
were introduced into a population of sows for which
the 10 serum samples were negative (corresponding to
0-27% within-group seroprevalence). The distribution
of the number of PRRSV positive serum samples per
group of animals in these 9 farms that did not vacci-
nate against PRRSV is given in Figure 1. 
Porcine circovirus type 2
None of the farms vaccinated against PCV2. All
serum samples were positive for antibodies against
PCV2.
Porcine parvovirus
Data was obtained from 23 farms.
In 20 farms (11 with purchased replacement gilts
and 9 with home-bred replacement gilts), the gilts and
sows were vaccinated against PPV. In all of these 20
farms, the gilts were seropositive and they were intro-
duced into a population of seropositive sows. 
In 3 farms with home-bred gilts, the gilts and sows
were not vaccinated against PPV. In these 3 farms, the
gilts were seropositive at the time of introduction into
the population of seropositive sows. In 1 of these 3
farms, the gilts were seropositive from the first blood
sampling on. In a second farm, the gilts were serone-
gative at the time of the first blood sampling and sero-
positive at the time of the second blood sampling. In
the third farm, the gilts were seropositive at the time of
the second blood sampling, but the blood samples
from the first blood sampling in these gilts were not
available.
Porcine enteroviruses
Data was obtained from 19 farms (10 with purcha-
sed replacement gilts and 9 with home-bred replace-
ment gilts). The distribution of the number of PEV
positive serum samples per group of animals in these
farms is given in Figure 2. The respective percentages
of serum samples positive for all 4 PEV serotypes in
Figure 1. Distribution of the number of positive serum
samples per group of animals for porcine reproductive
and respiratory syndrome virus (PRRSV) in 9 conven -
tional Belgian sow farms that did not vaccinate against
PRRSV. In each group of animals, 10 serum samples
were taken. White bars: young gilts (Gilts 1); grey bars:
the same gilts at the moment of introduction into the sow
population (Gilts 2); black bars: sows with at least 3
pari ties (Sows).
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each of the 3 overall groups were: 96% (all gilts sam-
pled before vaccination), 97% (all gilts sampled at in-
troduction into the sow population) and 95% (all
multiparous sows sampled). All the other serum sam-
ples were positive for 3 serotypes, except for one sin-
gle sow that was seropositive for only 2 serotypes.
Swine influenza viruses
For SIV, complete sets of serum samples were avai-
lable for 19 farms.
In 3 farms with purchased replacement gilts, the
gilts and sows were vaccinated against SIV. In 2 of
these 3 farms, H1N1- and H3N2-seropositive (10 po-
sitive serum samples, corresponding to 73-100% wit-
hin-group seroprevalence) but H1N2-seronegative
gilts (10 negative serum samples, corresponding to 0-
27% within-group seroprevalence) were introduced
into a population of sows for which the 10 serum sam-
ples were positive for H1N1, H3N2 and H1N2 (73-
100% within-group seroprevalence). In 1 of these 3
farms, H1N1-, H3N2 and H1N2-seropositive gilts
were introduced into a population of sows seroposi-
tive for H1N1, H3N2 and H1N2. 
In 16 farms (9 with home-bred replacement gilts
and 7 with purchased replacement gilts), the gilts and
sows were not vaccinated against SIV. On 10 of these
farms (7 with home-bred  replacement gilts and 3 with
purchased replacement gilts), the gilts for which all 10
serum samples were negative for at least 1 subtype
were introduced into a population of sows for which at
least 1 serum sample was positive for the correspon-
ding subtypes. More specifically, H1N1-seronegative
gilts were introduced into an H1N1-seropositive sow
population in 3 farms (2 with home-bred gilts and 1
with purchased gilts), H3N2-seronegative gilts were
introduced into an H3N2-seropositive sow population
in 6 farms (4 with home-bred gilts and 2 with purcha-
sed gilts) and H1N2-seronegative gilts were introdu-
ced into an H1N2-seropositive sow population in 7
farms (5 with home-bred gilts and 2 with purchased
gilts). In 1 farm with home-bred replacement gilts,
H1N2-seropositive gilts (10 positive serum samples,
corresponding to 73-100% within-group seropreva-
lence) were introduced into a sow population for
which the 10 serum samples were negative for H1N2
(0-27% within-group seroprevalence). In 5 farms (4
with purchased gilts and 1 with home-bred gilts), the
gilts introduced had the same immune status for all 3
subtypes as the multiparous sows. The distribution of
the number of SIV positive serum samples per group
of animals in the 16 farms that did not vaccinate
against SIV and for which complete data was obtained
is given in Figure 3. 
DISCUSSION
This survey suggests that the vast majority of con-
ventional Belgian gilts and sows are immune to PCV2
and PEV serotypes 1, 3, 6 and 8 due to natural infec-
Figure 2. Distribution of the number of positive serum samples per group of animals for porcine enterovirus (PEV)
serotypes 1, 3, 6 and 8 in 19 conventional Belgian sow farms. In each group of animals, 10 serum samples were taken.
White bars: young gilts (Gilts 1); grey bars: the same gilts at the moment of introduction into the sow population (Gilts
2); black bars: sows with at least 3 parities (Sows).
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tions. Consequently, we may assume that PCV2 and
PEV infections are of little importance in terms of cau-
sing reproductive failure in conventional Belgian gilts
and sows. Thus it seems unnecessary to vaccinate
these animals against PCV2 for the purpose of pre-
venting reproductive failure. Due to the small sample
sizes, however, it could not be demonstrated that all
Belgian gilts and sows are immune to PCV2 infection.
Thus it is not impossible that on some farms small
numbers of animals would benefit from PCV2 vacci-
nation before insemination. It also seems unnecessary
to immunize conventional gilts against PEV before in-
semination by bringing them into contact with feces
from weaned piglets. However, the results from the
present study also indicate that in some farms not all
gilts and sows are seropositive for all 4 embryopatho-
genic PEV serotypes. This may suggest that small
numbers of gilts and sows may be vulnerable to PEV-
induced reproductive failure.
This study also shows that not all conventional Bel-
gian pig farmers vaccinate their breeding stock against
PPV. In our opinion, this is not a wise decision. In 1 of
the farms that did not vaccinate against PPV, the gilts
seroconverted between the first and the second blood
sampling, which was only a few weeks before insemi-
nation. This may suggest that in this farm the gilts may
sooner or later be PPV-seronegative upon introduction
into the PPV-seropositive sow population. When these
pregnant gilts are subsequently infected with PPV, this
will presumably cause severe reproductive disorders
in them and financial losses for the farmer. Vaccina-
tion of gilts and sows is a cost-effective method for
controlling PPV-induced reproductive failure in pig
herds suffering endemic PPV infection (Parke and
Burgess, 1993; Gardner et al., 1996).
This survey also indicates that the majority of the
conventional Belgian gilts are seronegative for one or
more subtypes of SIV, thus indicating that the vacci-
nation of gilts against SIV may be of potential benefit
for farmers. The seroprevalence of SIV in sows seems
to be higher than in gilts, and therefore it seems wise
to decide to vaccinate sows against SIV based on the
results of serological analysis. Vaccination of comple-
tely SIV-seronegative animals with a currently regis-
tered H1N1- and H3N2-based commercial European
SIV vaccine will confer good protection against the
H1N1 and H3N2 subtypes, but not against the H1N2
subtype (Van Reeth et al., 2003b; Van Reeth et al.,
2004). In gilts and sows seropositive for one or more
subtypes, the administration of commercially availa-
ble SIV vaccines will dramatically increase Ab titers to
previously encountered subtypes and will even induce
H1N2 cross-reactive Ab in sows that were previously
infected with H1N1 and not with H1N2 (Van Reeth et
al., 2006). Vaccination of gilts and sows will also im-
prove maternal immunity and the protection of young
piglets against disease (Thacker, 2000). Farmers with
gilts and/or sows seronegative for one or more SIV
subtypes may thus benefit from vaccinating their gilts
and/or sows against SIV.
Finally, this survey demonstrates that in some con-
ventional Belgian sow farms wild-type PRRSV may
be transmitted from purchased, infection-seropositive
gilts to seronegative sows in gestation. Purchasing
PRRSV-positive gilts has previously been recognized
as a risk factor for the introduction of PRRSV into sow
herds (Mortensen et al., 2002; Pesente et al., 2006).
Therefore we advise suppliers of gilts and sow farmers
to have their gilts and sows regularly screened for
PRRSV. On the basis of these screening results, far-
mers can then either vaccinate non-immune animals
or else buy gilts from a different supplier. This proce-
dure will help farmers to prevent PRRSV infection of
non-immune animals during gestation and thus avoid
the serious reproductive problems caused by PRRSV.
Unfortunately, there does not exist a PRRSV vaccine
at present that can guarantee full clinical and virologi-
cal protection against infections with any wild-type
Figure 3. Distribution of the number of positive serum
samples per group of animals for swine influenza virus
(SIV) subtypes H1N1, H3N2 and H1N2 in 16 conven -
tional Belgian sow farms that did not vaccinate against
SIV. In each group of animals, 10 serum samples were
taken. White bars: young gilts (Gilts 1); grey bars: the
same gilts at the moment of introduction into the sow
population (Gilts 2); black bars: sows with at least 3
parities (Sows).
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PRRSV, especially when the wild-type virus and the
vaccine virus are genetically different (Opriessnig et
al., 2002; Labarque et al., 2004a; Cano et al., 2007;
Prieto et al., 2007). This implies that the decision to
use a certain PRRSV vaccine or to purchase gilts from
a different supplier should always be made together
with the farm veterinarian and, if necessary, together
with a virological expert. In any case, regular serolo-
gical screening of gilts and sows may be a good tool
for reducing the risk of reproductive failure due to
PRRSV in conventional Belgian sow herds. For this
reason, Animal Health Care Flanders is investigating
the feasibility of offering a PRRSV screening program
as a standard service for Belgian sow farms, in addi-
tion to the already existing service of supplying sow
farms with certified PRRSV-free boar semen (Van -
groenweghe et al., 2008). Due to high pig densities and
short distances to neighboring pig herds in certain
areas of Belgium, and due to the lack of marker vac-
cines and routine diagnostic tests adapted to marker
vaccines, a national PRRSV eradication program is not
feasible in Belgium at the present time, just as is the
case in the neighboring European countries as well
(Beilage and Bätza, 2007).
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